# Trial of Microplasmin Intravitreal Injection for Non-surgical Treatment of Focal Vitreomacular Adhesion. The MIVI-TRUST (TG-MV-006) Trial.

> **NCT00781859** · PHASE3 · COMPLETED · sponsor: **ThromboGenics** · enrollment: 326 (actual)

## Conditions studied

- Vitreomacular Adhesion

## Interventions

- **DRUG:** 125 µg Ocriplasmin
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00781859
- **Lead sponsor:** ThromboGenics
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-12
- **Primary completion:** 2010-03
- **Final completion:** 2010-04
- **Target enrollment:** 326 (ACTUAL)
- **Last updated:** 2014-12-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00781859

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00781859, "Trial of Microplasmin Intravitreal Injection for Non-surgical Treatment of Focal Vitreomacular Adhesion. The MIVI-TRUST (TG-MV-006) Trial.". Retrieved via AI Analytics 2026-08-17 from https://api.ai-analytics.org/clinical/NCT00781859. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*